Corporate and Finance
Attorneys in the Corporate & Finance Group represent start-up and emerging biotechnology companies, as well as venture capital and investment banking firms that are involved in biotechnology and medical devices. The firm provides comprehensive advice at all stages of development of such companies from the organizational and seed capital stage, to public offerings, strategic alliances, and mergers and acquisitions. Firm attorneys are actively engaged in assisting such companies when raising private and public capital. Representative engagements include:
Intellectual Property
The Corporate & Finance Group in conjunction with the Intellectual Property Group has extensive experience in the acquisition, transfer, and licensing of intellectual property rights pertaining to biotechnology, pharmaceutical, and other natural sciences, as well as product development and research arrangements. The firm assists clients in obtaining U.S. and foreign patent protection through sophisticated patent prosecution and licensing strategies designed to maximize the value of patent portfolios. The firm is regularly called on to provide formal patent opinions with regard to infringement, validity, and enforceability of patents in the areas of biotechnology, pharmaceuticals, and medical devices. In addition, our attorneys regularly conduct intellectual property due diligence in connection with mergers and acquisitions. Firm attorneys advise clients regarding a broad range of natural science-related technologies including vaccines, human and veterinary pharmaceutical products and treatment regimes, diagnostics, transgenic plants, gene therapies, automated nucleotide sequencers, specialty chemicals, polymers, and environment remediation. Representative engagements include: